f5 Therapeutics Incorporated
October 16, 2023
Franciscan B
Oncology
f5 Therapeutics is a privately held, pharmaceutical company that focuses on targeted protein degradation via ‘molecular glues.’ Our NExMod™ (Neosubstrate Expression Modulators) platform focuses on discovering novel targets for degradation to combat human disease across multiple therapeutic areas. Utilizing our proprietary methods, we have discovered multiple novel neosubstrates with the potential to revolutionize cancer care.
Speaker(s)
Gary Choy
Headquarters Location
San Diego, California
Innovation Supporter
CLS FAST advisory program
Website
https://www.f5therapeutics.com/
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)